Medically Reviewed by Jennifer Robinson, MD on May 20, 2021 Alkaline phosphatase is one kind enzyme found in your
body. Enzymes are proteins that help chemical reactions happen. For instance, they can break big molecules down into smaller parts, or they can help smaller molecules join together to form bigger structures. You have alkaline phosphatase throughout your body, including your liver,
digestive system, kidneys, and bones. If you show signs of liver disease or a bone disorder, your doctor may
order an alkaline phosphatase (ALP) test to measure the amount of the enzyme in your blood and help in diagnosing the problem. Sometimes it’s part of a broader group of tests called a routine liver or hepatic panel, which checks how your liver is working. If your liver isn’t working right, the amount of ALP in your blood may be high. Doctors often use the test to look for blocked bile ducts. Other conditions that can cause problems with your liver include: The test can also spot problems with your bones,
including: The lab will need a small amount of blood to perform the test. The person in charge of taking your blood will start by placing a
tight elastic band, called a tourniquet, around your upper arm. This makes your veins swell with blood. The lab tech will clean an area of your skin with a germ-killing solution. (It might be a spot inside your elbow or the back of your hand).
You’ll feel a small stick when the needle goes into your vein. The blood flows into a small vial attached to the needle. When the test is done, the lab tech will take the tourniquet off, and you’ll get a bandage on the spot where the needle went in. It takes only a few minutes. Taking blood samples is usually very safe. Some things that might happen after the test include a
bruise at the spot where the needle went in, and a little dizziness. There’s also a slight chance of infection.Why Would I Get This Test?
How Is the Test Done?
You may have to limit food and
liquids for several hours before the test. Some medicines interfere with the results, so make sure your doctor knows about all drugs you take, including over-the-counter medicines, vitamins, and supplements. Be sure
to let your doctor know if you are pregnant, because that will increase the level of ALP in your blood. It generally takes 1-2 days for results to come back from the lab. Higher-than-normal ALP levels for your age and sex may not necessarily mean you have a problem. (Children and
teens naturally have higher levels than adults because their bones are still developing). If your ALP level is high, your doctor may have you take another test, called an ALP isoenzyme test, to determine whether the alkaline phosphatase in your blood is coming from your liver or your bones. Low levels of ALP indicate a deficiency in zinc and magnesium but can also be an indicator of a rare
genetic disease called hypophosphatasia (HPP), which affects bones and teeth.How Do I Prepare?
What Do My Results Mean?
Clinical Trial
Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals
L Lind et al. Scand J Urol Nephrol. 1991.
Abstract
Raised levels of alkaline phosphatases (ALP) are seen in conditions with a high bone turn-over, such as in primary and secondary hyperparathyroidism (HPT). To study the effects of active vitamin D treatment on ALP, alphacalcidol (1-alpha-hydroxyvitamin D3), was given to patients with primary HPT as well as HPT secondary to chronic renal failure and also to healthy, euparathyroid subjects. Oral alphacalcidol (1 microgram daily) significantly reduced serum ALP (3.2 +/- 1.1 to 2.8 +/- 1.2 mu kat/l, p less than 0.05) in a 6-month double-blind, placebo-controlled study in patients with mild primary HPT, and alphacalcidol given intravenously to uremic subjects induced a reduction in serum ALP levels (3.5 +/- 3.1 to 2.6 +/- 1.7 mu kat/l, p less than 0.05) during a 4 months' study. A reduction in serum ALP was also seen in the euparathyroid subjects (2.4 +/- 0.77 to 2.2 +/- 0.64 mu kat/l, p = 0.03). This study indicates that treatment with active vitamin D is effective in reducing the increased bone turnover seen in subjects with both primary and secondary HPT.
Similar articles
[Evaluation of the treatment efficacy of secondary hyperparathyroidism with oral pulse doses of alphacalcidol].
Switalski M, Kuriga M, Wańkowicz Z. Switalski M, et al. Pol Arch Med Wewn. 1997 Oct;98(10):358-65. Pol Arch Med Wewn. 1997. PMID: 9557090 Clinical Trial. Polish.
[Oral pulsatile therapy with active vitamin D3 metabolites--an efficient method of parathyroid hormone synthesis suppression in uremic patients with severe hyperparathyroidism. A pilot study].
Matuszkiewicz-Rowińska J, Niemczyk S, Bogdańska-Straszyńska B, Ostrowski K. Matuszkiewicz-Rowińska J, et al. Pol Arch Med Wewn. 1993 Feb;89(2):95-101. Pol Arch Med Wewn. 1993. PMID: 8502602 Polish.
Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
Koskimies O, Ala-Houhala M. Koskimies O, et al. Clin Nephrol. 1996 Jul;46(1):70-1. Clin Nephrol. 1996. PMID: 8832157
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
Dong BJ. Dong BJ. Clin Ther. 2005 Nov;27(11):1725-51. doi: 10.1016/j.clinthera.2005.11.015. Clin Ther. 2005. PMID: 16368445 Review.
Cited by
Risk Factors for Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism after Total Parathyroidectomy.
Wen P, Xu L, Zhao S, Gan W, Hou D, Zhang L, Cao J, Xiong M, Jiang L, Yang J. Wen P, et al. Int J Endocrinol. 2021 Apr 2;2021:6613659. doi: 10.1155/2021/6613659. eCollection 2021. Int J Endocrinol. 2021. PMID: 33868402 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
- Taylor & Francis
Medical
- Genetic Alliance
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program